Clinical Trials Browser

Phase 4 × OTHER × Vortioxetine × Clear all

NCT02637466 2016-09-30

Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

Phase 4 Withdrawn

Unipolar Major Depression